KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...

In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug ...

Shares of Cogent Biosciences were higher after the company disclosed what it called positive top-line results from a recent trial of its treatment for certain types of mastocytosis, a rare disorder in ...

If you're worried about not having a clean bowel movement, try chia seeds. A dietitian shares 6 ways they can relieve ...

Due to health concerns, animal welfare, or safety regulations, certain foods that are considered delicacies in other countries are banned within U.S. borders. Some of these items are prohibited due to ...

Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties ...